Company Filing History:
1 out of 261 
1 out of 601 
Years Active: 2025
Title: Giedre Krenciute: Innovator in Chimeric Antigen Receptors
Introduction
Giedre Krenciute is a notable inventor based in Memphis, TN (US). She has made significant contributions to the field of immunology, particularly in the development of chimeric antigen receptors (CARs). Her work focuses on enhancing the effectiveness of these receptors in targeting specific cancer cells.
Latest Patents
Giedre Krenciute holds a patent for "Chimeric antigen receptors with MYD88 and CD40 costimulatory domains." This innovative application relates to a chimeric antigen receptor that targets Eph receptors, facilitating the activation of co-stimulatory pathways. Additionally, the application encompasses polynucleotides encoding the chimeric antigen receptor, vectors, and host cells that incorporate this receptor. The methods outlined in her patent aim to improve the in vivo effector function of host cells containing the chimeric antigen receptor.
Career Highlights
Throughout her career, Giedre has worked with prestigious institutions, including St. Jude Children's Research Hospital and Baylor College of Medicine. Her research has significantly advanced the understanding and application of CAR technology in cancer treatment.
Collaborations
Giedre has collaborated with esteemed colleagues such as Stephen Gottschalk and Brooke Prinzing, contributing to the advancement of research in her field.
Conclusion
Giedre Krenciute's innovative work in chimeric antigen receptors exemplifies her commitment to improving cancer therapies. Her contributions continue to influence the landscape of immunological research and treatment.